We are live on
!
Find out more
Voloridge Investment Management Portfolio holdings
AUM
$25B
1-Year Est. Return
28.08%
This Fund
S&P 500
This Quarter
Est. Return
+6.27%
1 Year Est. Return
+28.08%
3 Year Est. Return
+85.2%
5 Year Est. Return
+73.43%
10 Year Est. Return
+582.16%
AUM
$17.9B
AUM Growth
-$597M
(-3.2%)
Cap. Flow
-$1.32B
Cap. Flow
% of AUM
-7.36%
Top 10 Holdings %
Top 10 Hldgs %
8.81%
Holding
1,709
New
345
Increased
450
Reduced
603
Closed
311
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$146M |
| 2 |
Apple
AAPL
|
+$129M |
| 3 |
Tesla
TSLA
|
+$110M |
| 4 |
Medtronic
MDT
|
+$104M |
| 5 |
Verizon
VZ
|
+$102M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$181M |
| 2 |
Microsoft
MSFT
|
+$177M |
| 3 |
Comcast
CMCSA
|
+$173M |
| 4 |
Adobe
ADBE
|
+$163M |
| 5 |
Broadcom
AVGO
|
+$157M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.34% |
| 2 | Healthcare | 14.31% |
| 3 | Consumer Discretionary | 12.9% |
| 4 | Industrials | 11.52% |
| 5 | Financials | 10.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
LPL Financial
LPLA
$29.2B
| $26.7M | 0.15% |
+123,541
| New | +$28.9M |
|
202
Packaging Corp of America
PKG
$22.9B
| $26.6M | 0.15% |
207,916
-74,040
| -26% | -$9.28M |
|
203
Tenet Healthcare
THC
$20.9B
| $26.2M | 0.15% |
537,685
+491,568
| +1,066% | +$22.7M |
|
204
Textron
TXT
$15.2B
| $26M | 0.14% |
367,000
+246,387
| +204% | +$16.7M |
|
205
Eli Lilly
LLY
$1.08T
| $25.6M | 0.14% |
+69,995
| New | +$24.8M |
|
206
IDEX
IEX
$17.5B
| $25.4M | 0.14% |
111,341
+107,363
| +2,699% | +$24M |
|
207
Trimble
TRMB
$13.5B
| $25.4M | 0.14% |
502,302
+106,494
| +27% | +$5.93M |
|
208
Amazon
AMZN
$2.94T
| $25.3M | 0.14% |
+301,771
| New | +$29.8M |
|
209
Altria Group
MO
$109B
| $25.3M | 0.14% |
552,694
+460,985
| +503% | +$20.9M |
|
210
ASML
ASML
$691B
| $25.1M | 0.14% |
45,872
-68,655
| -60% | -$36M |
|
211
Colgate-Palmolive
CL
$73.6B
| $24.9M | 0.14% |
316,229
-52,007
| -14% | -$3.9M |
|
212
T-Mobile US
TMUS
$192B
| $24.6M | 0.14% |
+175,444
| New | +$25.2M |
|
|
KRTX
213
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $24.5M | 0.14% |
124,655
-38,972
| -24% | -$8.36M |
|
214
Zoom
ZM
$31.1B
| $24.4M | 0.14% |
360,275
-252,079
| -41% | -$19.1M |
|
215
Gold Fields
GFI
$36B
| $24.2M | 0.13% |
2,336,569
-1,126,720
| -33% | -$10.9M |
|
216
Exelon
EXC
$46.2B
| $24.2M | 0.13% |
558,969
+493,259
| +751% | +$19.5M |
|
217
Booz Allen Hamilton
BAH
$9.45B
| $24.1M | 0.13% |
230,779
+194,249
| +532% | +$20.2M |
|
218
PVH
PVH
$3.91B
| $24.1M | 0.13% |
340,958
-383,535
| -53% | -$22.9M |
|
219
Bio-Rad Laboratories Class A
BIO
$9.53B
| $24M | 0.13% |
57,093
+25,918
| +83% | +$10.5M |
|
|
BNY
220
Bank of New York Mellon
BNY
$109B
| $23.8M | 0.13% |
523,202
+34,670
| +7% | +$1.49M |
|
221
APA Corp
APA
$14.2B
| $23.6M | 0.13% |
505,056
-83,773
| -14% | -$3.75M |
|
222
Steris
STE
$23.2B
| $23.6M | 0.13% |
127,629
+74,447
| +140% | +$13.1M |
|
223
Toro Company
TTC
$9.41B
| $23.4M | 0.13% |
206,806
+168,159
| +435% | +$17.8M |
|
224
American Express
AXP
$230B
| $23.3M | 0.13% |
157,634
+119,083
| +309% | +$17.6M |
|
225
Entegris
ENTG
$23B
| $23.3M | 0.13% |
+354,831
| New | +$26.1M |
|
Similar funds
CS
VAI
Voloridge Investment Management's Q4 2022 Portfolio in Review
As of Q4 2022, Voloridge Investment Management held 1,709 positions worth $17.9B, down 3.2% from $18.5B the previous quarter. Its ten largest holdings account for 8.8% of the portfolio.
Voloridge Investment Management withdrew a net $1.32B in Q4 2022, closing 311 positions and reducing 603 holdings. Its most notable exit was Berkshire Hathaway Class B, an estimated $181M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Voloridge Investment Management opened a new position in Edwards Lifesciences worth $142M.
- Voloridge Investment Management's largest Q4 2022 buy was Edwards Lifesciences: 1,898,822 shares worth $142M.
- Voloridge Investment Management added most to Tesla in Q4 2022, an estimated $110M increase.
- Voloridge Investment Management's biggest Q4 2022 reduction was Microsoft, cutting an estimated $177M.
- Voloridge Investment Management fully exited Berkshire Hathaway Class B in Q4 2022, selling an estimated $181M.
- Voloridge Investment Management's ten largest holdings make up 8.8% of its $17.9B portfolio in Q4 2022.
- Voloridge Investment Management opened 345 new positions and closed 311 in Q4 2022.
- Voloridge Investment Management's portfolio value fell 3.2% quarter-over-quarter to $17.9B.
Based on Voloridge Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.